Subbu Nambi
Stock Analyst at Guggenheim
Total Price Targets
18
Stocks Covered
15
Sectors
Healthcare, Industrials
Most Recent
Jan 26, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Subbu Nambi
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| ILMN | Illumina, Inc. | $170.00 | $134.56 | +26.3% | 1 | Jan 26, 2026 |
| PSNL | Personalis, Inc. | $13.00 | $5.67 | +129.1% | 1 | Jan 26, 2026 |
| CSTL | Castle Biosciences, Inc. | $47.00 | $24.80 | +89.5% | 2 | Jan 26, 2026 |
| WAT | Waters Corporation | $440.00 | $306.16 | +43.7% | 1 | Jan 6, 2026 |
| VCYT | Veracyte, Inc. | $50.00 | $33.03 | +51.4% | 1 | Jan 5, 2026 |
| GH | Guardant Health, Inc. | $115.00 | $87.52 | +31.4% | 2 | Jan 5, 2026 |
| BRKR | Bruker Corporation | $53.00 | $36.66 | +44.6% | 2 | Jan 5, 2026 |
| GRAL | GRAIL, Inc. | $100.00 | $54.34 | +84.0% | 1 | Nov 12, 2025 |
| CAI | Caris Life Sciences, Inc. | $32.00 | $18.46 | +73.3% | 1 | Jul 13, 2025 |
| DHR | Danaher Corporation | $275.00 | $175.31 | +56.9% | 1 | Dec 19, 2024 |
| CYRX | Cryoport, Inc. | $11.00 | $10.40 | +5.8% | 1 | Dec 19, 2024 |
| MYGN | Myriad Genetics, Inc. | $29.00 | $4.89 | +493.0% | 1 | Aug 7, 2024 |
| SOPH | SOPHiA GENETICS S.A. | $6.00 | $5.29 | +13.4% | 1 | Jun 27, 2024 |
| NAUT | Nautilus Biotechnology, Inc. | $6.00 | $2.68 | +123.9% | 1 | Jun 27, 2024 |
| TWST | Twist Bioscience Corporation | $53.00 | $60.67 | -12.6% | 1 | Jun 5, 2024 |
Recent Activity
- Jan 26, 2026— Set$47.00price target onCSTL(Castle Biosciences, Inc.)
- Jan 26, 2026— Set$13.00price target onPSNL(Personalis, Inc.)
- Jan 26, 2026— Set$170.00price target onILMN(Illumina, Inc.)
- Jan 6, 2026— Set$440.00price target onWAT(Waters Corporation)
- Jan 5, 2026— Set$50.00price target onVCYT(Veracyte, Inc.)
- Jan 5, 2026— Set$53.00price target onBRKR(Bruker Corporation)
- Jan 5, 2026— Set$115.00price target onGH(Guardant Health, Inc.)
- Nov 12, 2025— Set$100.00price target onGRAL(GRAIL, Inc.)
- Jul 13, 2025— Set$32.00price target onCAI(Caris Life Sciences, Inc.)
- Mar 28, 2025— Set$30.00price target onCSTL(Castle Biosciences, Inc.)
- Dec 19, 2024— Set$275.00price target onDHR(Danaher Corporation)
- Dec 19, 2024— Set$11.00price target onCYRX(Cryoport, Inc.)
- Dec 19, 2024— Set$72.00price target onBRKR(Bruker Corporation)
- Aug 7, 2024— Set$29.00price target onMYGN(Myriad Genetics, Inc.)
- Jun 28, 2024— Set$36.00price target onGH(Guardant Health, Inc.)
- Jun 27, 2024— Set$6.00price target onSOPH(SOPHiA GENETICS S.A.)
- Jun 27, 2024— Set$6.00price target onNAUT(Nautilus Biotechnology, Inc.)
- Jun 5, 2024— Set$53.00price target onTWST(Twist Bioscience Corporation)
Frequently Asked Questions
Who is Subbu Nambi?
Subbu Nambi is a stock analyst at Guggenheim covering 15 stocks primarily in Healthcare, Industrials. They have issued 18 price targets since Jun 5, 2024.
What stocks does Subbu Nambi cover?
Subbu Nambi currently covers 15 stocks, including CSTL, GH, BRKR, ILMN, PSNL.
What is Subbu Nambi's latest price target?
Subbu Nambi's most recent price target was $47.00 on CSTL (Castle Biosciences, Inc.), set on Jan 26, 2026.
What is Subbu Nambi's highest price target?
Subbu Nambi's highest issued price target is $440.00 on WAT, set on Jan 6, 2026.
More Analysts at Guggenheim
Coverage based on publicly published price targets. Not investment advice.